FindTrial
Sign In

Serum vitamin B, folate, homocysteine and micronucleus status in patients with inflammatory bowel disease in Korea

Measuring cell structure damage and gene mutations in peripheral blood lymhocytes in patients with inflammatory bowel disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0001650
Enrollment
60
Registered
2015-10-07
Start date
2011-11-14
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Gachon University Gil Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.The patients diagnosed with inflammatory bowel disease in our or other hospital, and currently under observation. 2.Clinical, histological, endoscopic findings were confirmed in patients with inflammatory bowel disease

Exclusion criteria

Exclusion criteria: 1.Patients with liver or kidney dysfunction is accompanied 2.Previous history of cancer 3.Patients taking the drug containing the cobalamin, folate or pyridoxine within last 4 weeks.

Design outcomes

Primary

MeasureTime frame
In peripheral blood vitamin B12, B6, folic acid, homocysteine measurement, etc.;Measuring the frequency of micronuclei in peripheral blood lymphocytes—

Secondary

MeasureTime frame
Gene acting on vitamin B12 and folic acid—

Countries

Korea, Republic of

Contacts

Public ContactSu Young Kim

Gachon University Gil Medical Center

breeze1212@naver.com+82-32-460-3778

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026